Robotic Cell Processing Workcell for Sterile Flexible Manufacturing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional cell product manufacturing processes are cumbersome, expensive, and prone to human error, lacking end-to-end process flexibility, robustness, and scalability, and often require costly cleanroom facilities.

Innovation Solution

A system comprising a cartridge with multiple modules and a robot for automated cell processing, enabling sterility, reduced labor costs, and improved flexibility, scalability, and reliability by moving the cartridge between instruments within a workcell.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional manual operations are used in biosafety cabinets and clean rooms, then sterility can be maintained, but labor costs and operational complexity increase significantly

Engineering Contradiction:
ImprovesterilityVSAvoidoperational complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system employs self-service automation where robotic instruments autonomously perform cell processing operations without human intervention. The automated instruments handle reagent preparation, cell manipulation, and processing steps independently, eliminating the need for skilled technicians to manually operate in clean rooms while maintaining sterility through closed-system design.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

Manual mechanical operations performed by technicians in biosafety cabinets are replaced with automated robotic systems. The patent substitutes human hands and manual manipulation with robotic instruments that can precisely handle cells and reagents, reducing operational complexity while maintaining or improving sterility through programmable, contamination-free operations.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Adaptability or versatility

If multiple manual reagent preparation and instrument manipulation steps are employed, then process flexibility can be achieved, but process duration extends to several days or weeks

Engineering Contradiction:
Improveprocess flexibilityVSAvoidprocess duration
Core Design Contradiction:
Adaptability or versatilityVSLoss of time

Solution Approach 1:

The automated system enables continuous processing where cell therapy manufacturing operations proceed without interruption. Multiple processing steps are executed in sequence without the delays inherent in manual operations, as robotic instruments can immediately transition between tasks. This continuous automation reduces process duration from days or weeks to hours while maintaining flexibility through programmable protocols.

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The system performs preliminary preparation of reagents and processing parameters before cell therapy manufacturing begins. Automated instruments pre-configure reagent volumes, temperatures, and processing conditions in advance, eliminating the need for time-consuming manual setup during the actual cell processing, thus reducing overall process duration while maintaining adaptability.

Inventive Principle:
Principle #10Preliminary action

3Extent of automation

If pre-configured instrumentation and tubing sets are used in automated systems, then automation is achieved, but operational flexibility is limited

Engineering Contradiction:
ImproveautomationVSAvoidoperational flexibility
Core Design Contradiction:
Extent of automationVSAdaptability or versatility

Solution Approach 1:

The system employs dynamic, reconfigurable instrumentation rather than fixed pre-configured setups. Robotic instruments can be programmatically adjusted to perform different cell processing operations, and tubing connections can be dynamically established or modified based on the specific manufacturing protocol required. This dynamic adaptability maintains full automation while enabling flexibility across various cell therapy processes.

Inventive Principle:
Principle #15Dynamics

4Reliability

If skilled laboratory technicians perform manual operations, then process robustness can be maintained, but labor costs and risk of human error increase

Engineering Contradiction:
Improveprocess robustnessVSAvoidlabor costs
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The automated system incorporates feedback mechanisms where sensors and controllers continuously monitor processing conditions and automatically adjust parameters to maintain process robustness. This closed-loop control eliminates the need for skilled technicians to manually monitor and adjust operations, reducing labor costs while maintaining or improving process reliability through consistent, error-free automated execution.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS12551887B2Apparatus and method for control of cell processing system
Publication Date: 2026.02.17 CELLARES CORP
  • US12551887B2 patent drawing
  • US12551887B2 patent drawing
  • US12551887B2 patent drawing

AI summary

Disclosed herein are cell processing systems, devices, and methods thereof. A system for cell processing may comprise a plurality of instruments each independently configured to perform one or more cell processing operations upon a cartridge, and a robot capable of moving the cartridge between each of the plurality of instruments.